dc.contributor.author | Gündeş, İ | |
dc.contributor.author | Kıvanç, Demet | |
dc.contributor.author | Nursal, AF | |
dc.contributor.author | Oyacı, Y | |
dc.contributor.author | Pehlivan, Sacide | |
dc.contributor.author | Pehlivan, M | |
dc.date.accessioned | 2021-03-02T17:21:43Z | |
dc.date.available | 2021-03-02T17:21:43Z | |
dc.identifier.citation | Pehlivan M., Nursal A., Gündeş İ., Oyacı Y., Kıvanç D., Pehlivan S., "Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study.", Endocrine, metabolic & immune disorders drug targets, 2020 | |
dc.identifier.issn | 1871-5303 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_cb72f433-80de-4c1c-9a3a-345face9bdec | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/3772 | |
dc.identifier.uri | https://doi.org/10.2174/1871530320999200818102731 | |
dc.language.iso | eng | |
dc.title | Role of MIF -173G/C and Mbl2 codon 54A/B variants in risk of multiple myeloma: An association study. | |
dc.type | Makale | |
dc.relation.journal | Endocrine, metabolic & immune disorders drug targets | |
dc.contributor.department | , , | |
dc.contributor.firstauthorID | 2257863 | |